Document is current
Any future updates will be listed below
-
Authors
Kim, Ho Cheol
Chandel, Abhimanyu
King, Christopher S.
Kim, Min Jee
Shawabkeh, Malek
Arunachalam, Ambalavanan
Tomic, Rade
Nathan, Steven D.
- License Information
-
More Information
Article History
Received: 8 November 2024
Accepted: 28 December 2024
First Online: 22 January 2025
Declarations
:
: SDN is a consultant and is on the speakers bureau for both Boehringer-Ingelheim and United Therapeutics. He has also received research funding from both Companies. He is also on the steering committee for IPF studies by Tvardi and Avalyn Pharma. CSK is a speaker for and has served on advisory boards for United Therapeutics and served on advisory boards for Merck and Jannsen. RT served on advisory boards for TFF and is a speaker for Boehringer Ingelheim. None of the other investigators have any conflicts of interest with regards to this study.
